In an article titled “VIDEO: Hyperinflammatory ARDS responds to simvastatin”, published June 2, 2017, Dr. Carolyn S. Calfee’s statement on the study results was misquoted. Hypoinflammatory patients treated with simvastatin may have improved outcomes, compared with hyperinflammatory patients treated with placebo.
AT WCLC 2016 VIENNA (FRONTLINE MEDICAL NEWS) – The addition of ganetespib to docetaxel ...
The number of childhood cancer survivors has increased significantly since 2005, but the majority ...
FROM JAMDA Short-term cognitive-behavioral therapy is an effective intervention for geriatric patients with comorbid ...
